Michael A. Klobuchar - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Role
Chief Operating Officer
Signature
/s/ Benjamin Thorner, Attorney-in-Fact
Issuer symbol
EIKN
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
3
Filing time
04 Feb 2026, 21:19:29 UTC
Previous filing
01 May 2025
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klobuchar Michael A Chief Operating Officer C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE /s/ Benjamin Thorner, Attorney-in-Fact 04 Feb 2026 0001871957

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 134,087 $9.85 Direct F1
holding EIKN Stock Option (Right to Buy) 04 Feb 2026 Common Stock 40,226 $9.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying the option vest on the vesting start date, and 1/48th of the shares underlying the option vest on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for 35 months, subject to the Reporting Person's continued service through each date.
F2 The shares underlying the option will vest in equal monthly installments for four years after the vesting starting date, subject to the Reporting Person's continued service through each date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney